The Company is engaged in the research, development, production, marketing and distribution of probiotics products, which contains live microbial food supplements which beneficially affect the host by improving its intestinal microbial balance.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Latest quarterly results for this developer and distributor of probiotics products show the following:
net sales up 61.8% YOY
Gross profit up 56.8%
Gross margin is 68.6%
Operating income +72.8% YOY
Diluted EPS up 44% (+18% surprise)
Conservatively this stock should grow 2 to 4 times in the next 18 to 36 months.